News
A CRISPR/Cas9-based galactose screening identifies key mitochondrial genes involved in OXPHOS and oxidative metabolism, ...
News-Medical.Net on MSN13h
Metrion Biosciences launches NaV1.9 high-throughput screening assay to strengthen screening portfolio and advance research on new medicines for pain("Metrion"), the specialist preclinical contract research organization (CRO) and a global leader in ion channel services, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback